EUVIMEDEUVIMED entdecken
Crossref

Hemostatic function, immunomodulatory capacity, and effects of lipemia in cold‐stored whole blood

Joanne C G Tan iD, Htet Htet Aung, Denese C Marks iD

Transfusion · 2025

DOI: 10.1111/trf.18065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Joanne C G Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia. Hauptthemen laut MEDLINE: Blood Preservation, Hemostasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whole blood (WB) is increasingly being used for resuscitation of trauma patients. Although platelet‐, red blood cell (RBC)‐ and plasma‐specific parameters in cold‐stored WB are well characterized, there has been limited investigation of biological response modifiers (BRMs), which may induce adverse reactions in recipients. The aim of this study was to evaluate the quality and function of RBC, platelets, plasma proteins, and BRMs in cold‐stored WB during storage.

Methods

WB ( n = 24) was collected into collected into citrate‐phosphate‐dextrose (CPD) anticoagulant, held overnight, processed through a platelet‐sparing filter, and stored at 2–6°C for 21 days. RBC, platelet, coagulation factor quality and function, and BRM concentrations were measured throughout the duration of storage.

Results

WB was effectively leukoreduced, with 99.98% reduction in leukocyte count and 81% platelet count recovery following filtration. Five WB units were significantly lipemic, with a visible lipid layer appearing after being cold storage overnight. These were more turbid with higher hemolysis compared to non‐lipemic units ( p = .023). Despite a decrease in platelet count during storage ( p < .001), hemostatic function as measured by thromboelastography was maintained for at least 21 days (R time and maximum amplitude; both p < .001). There was a significant increase in PF4, CD62P, and RANTES during cold storage (all p < .001).

Discussion

WB retains hemostatic potential for at least 21 days of cold storage, and with further development, may be suitable for transfusion in Australia. Before implementation in Australia, quality control measures for lipemia and hemolysis would need to be defined as part of our manufacturing processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PreservationHemostasisHumansThrombelastographyBlood PlateletsErythrocytesHemolysisFemaleMale

Stichwörter der Autor:innen

WB in vitro qualityhemostasislipemiasoluble mediatorswhole blood

Autor:innen und Institutionen

  • Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Joanne C G Tan, Denese C Marks

Zitieren

APA

Tan, J. C. G., Aung, H. H., & Marks, D. C. (2025). Hemostatic function, immunomodulatory capacity, and effects of lipemia in cold‐stored whole blood. Transfusion. https://doi.org/10.1111/trf.18065

Vancouver

Tan JCG, Aung HH, Marks DC. Hemostatic function, immunomodulatory capacity, and effects of lipemia in cold‐stored whole blood. Transfusion. 2025. doi:10.1111/trf.18065

BibTeX
@article{Tan2025,
  author = {Tan, Joanne C G and Aung, Htet Htet and Marks, Denese C},
  title = {Hemostatic function, immunomodulatory capacity, and effects of lipemia in cold‐stored whole blood},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18065}
}
Kostenlos starten →